Nordson Corporation to Acquire Atrion Corporation

May 28, 2024

Nordson Corporation has entered into a definitive agreement to acquire Atrion Corporation for $460.00 per share in cash, representing an aggregate enterprise value of approximately $800 million. The acquisition expands Nordson's medical portfolio into infusion and cardiovascular therapies and is expected to close prior to Nordson's fiscal year-end 2024, subject to regulatory and stockholder approvals.

Buyers
Nordson Corporation
Targets
Atrion Corporation
Industry
Medical Devices
Location
Texas, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.